Construction of Toll Group’s new cutting-edge healthcare facility at the Melbourne Airport Business Park has been completed.
The 10,000-square-metre temperature-controlled facility was custom built to support the operations of leading global biotechnology company, CSL Seqirus, which is situated on the adjoining site.
Toll is a leading supply chain partner to CSL Seqirus which produces influenza vaccines, antivenoms and blood plasma to Australia and the rest of the world.
Melbourne Airport Program Manager, Cesar Gomez, said the new facility is a significant addition to Toll’s extensive network servicing the healthcare industry.
“Toll Healthcare’s new facility has received one of the highest ratings from customer auditors in the region and is well on track to receive an A1 compliance rating from the Therapeutic Goods Administration,” he said.
“Its advanced specifications on security, mechanical systems and electrical redundancy are critical for the nature of their operations.”
Constructed by CMW Design & Construct, Gomez explained the facility’s development also had a heavy focus on sustainability – targeting a 5 Star Green Star building certification.
“This building is set to be the first within the Melbourne Airport Business Park to achieve such a significant accreditation,” he said.
Construction of the new facility was first announced earlier this year, where it was reported that the $20 million facility would eventually become Toll’s largest healthcare site in Victoria.
In other news, Brisbane-based refrigerated transport company, SLR Trans, is celebrating 10 years of operations.
The post Toll Group opens new Melbourne facility appeared first on Trailer Magazine.